{
  "ptid_time": "027_S_4729_2014-06-16",
  "img_path": "/data/qiuhui/data/adni/images/027_S_4729/2014-06-16/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 47,319 mm³, 68.6% above the reference mean. With a Z-score of 1.57 (94.2th percentile), this represents moderate enlargement; hippocampal volume measures 4,884 mm³, 31.4% below the reference mean. With a Z-score of -2.88 (0.2th percentile), this represents significant atrophy; whole brain volume measures 876,888 mm³, 10.0% below the reference mean. With a Z-score of -1.26 (10.3th percentile), this represents mild atrophy; entorhinal cortex volume measures 3,066 mm³, 16.5% below the reference mean. With a Z-score of -1.01 (15.5th percentile), this represents mild atrophy; fusiform gyrus volume measures 14,054 mm³, 17.4% below the reference mean. With a Z-score of -1.58 (5.7th percentile), this represents moderate atrophy; middle temporal gyrus volume measures 12,007 mm³, 37.4% below the reference mean. With a Z-score of -3.24 (0.1th percentile), this represents profound atrophy. ",
  "text_data": "Age is 79.8 years. Gender is Female. Education: 19 years. MMSE: 24.0. MoCA: 15.0. Logical Memory: 1.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.50 SUVR (profound elevated); Amyloid beta: 914.90 pg/mL (normal ); Total tau: 827.60 pg/mL (profound elevated); Phosphorylated tau: 75.09 pg/mL (profound elevated). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The imaging data show significant hippocampal atrophy (Z-score -2.88, 0.2th percentile) and profound middle temporal gyrus atrophy (Z-score -3.24, 0.1th percentile), both strongly associated with Alzheimer's pathology. The CSF biomarkers (profoundly elevated T-tau and P-tau) and AV45-PET (profoundly elevated amyloid) confirm Alzheimer's pathophysiology despite normal Aβ (possibly due to assay variability). Cognitive scores (MMSE 24, MoCA 15) indicate moderate impairment.  \n\n**Diagnosis:** **Dementia** (likely Alzheimer’s disease, atypical variant given disproportionate temporal atrophy).  \n**Confidence:** **High** (imaging and biomarkers align with neurodegenerative dementia, though the Aβ discrepancy warrants clinical correlation).",
  "timestamp": "2025-07-26T03:57:08.062052"
}